A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients
This study has been completed.
Information provided by:
NIH AIDS Clinical Trials Information Service
First received: November 2, 1999
Last updated: June 23, 2005
Last verified: April 1996
To determine the safety and efficacy of oral valacyclovir hydrochloride ( 256U87 ) compared to acyclovir in the treatment of recurrent anogenital herpes in HIV-infected patients with CD4 counts = or > 100 cells/mm3.
Drug: Valacyclovir hydrochloride
||Endpoint Classification: Safety Study
Primary Purpose: Treatment
||A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Patients must have:
- HIV infection with CD4 counts = or > 100 cells/mm3.
- Documented culture of anogenital herpes simplex virus (HSV) within the last 5 years.
- History of recurrent anogenital HSV infection, with a recurrence (with or without culture) within 1 year prior to study.
Patients with the following symptoms and conditions are excluded:
- Malabsorption or vomiting that would potentially limit the retention and absorption of oral therapy.
- Systemic antiherpes medication.
Patients with the following prior conditions are excluded:
History of hypersensitivity to acyclovir.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00002084
No publications provided
History of Changes
|Other Study ID Numbers:
|Study First Received:
||November 2, 1999
||June 23, 2005
||United States: Food and Drug Administration
Keywords provided by NIH AIDS Clinical Trials Information Service:
Acquired Immunodeficiency Syndrome
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on July 28, 2015
DNA Virus Infections
Skin Diseases, Infectious
Skin Diseases, Viral